Results presented for KEYNOTE-046 study of ADXS-PSA plus pembrolizumab in patients with mCRPC June 28, 2018
Preliminary data from phase Ib/II study of PCM-075 in combination with cytarabine or decitabine June 28, 2018
PharmaMar and Chugai announce early termination of the license agreement for Zepsyre in Japan June 28, 2018
FDA grants orphan drug designation for cannabidiol as treatment of autoimmune hepatitis June 28, 2018
First patient dosed in phase II study of REL-1017 in patients with major depressive disorder June 28, 2018
FDA grants priority review for glasdegib in previously untreated acute myeloid leukemia June 28, 2018
RSS